AIM Financials
Aim Immunotech Inc - Financial statements & key metrics
Stock Price
$0.69
Market Cap
$2.79M
EPS
$-18.16
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$170000.00
Gross Profit
$139000.00
Operating Income
$-19.77M
Net Income
$-17.32M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$8.61M
Total Liabilities
$9.93M
Shareholders Equity
$-1.32M
Cash & Equivalents
$1.70M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-14.89M
CapEx
$18000
Free Cash Flow
$-14.91M
Profitability Metrics
Gross Margin
15.2%
Operating Margin
-94.1%
ROE
-31.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AIM revenue?
AIM's most recent quarterly revenue was $170000.00. Annual revenue can be calculated by summing the four most recent quarters.
Is AIM profitable?
AIM reported a loss of $17.32M in the most recent quarter.
What is AIM market cap?
AIM has a market capitalization of $2.79M, making it a small-cap stock.
Does AIM have debt?
View AIM's balance sheet for debt information.
What is AIM cash flow?
AIM's most recent quarterly free cash flow was $-14.91M.